.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Metoprolol tartrate - Generic Drug Details

« Back to Dashboard
Metoprolol tartrate is the generic ingredient in two branded drugs marketed by Novartis, Mylan, Gland Pharma Ltd, Luitpold, Sagent Strides, Watson Labs, Hospira, Teva Pharms, Aurobindo Pharma, Teva, Sun Pharm Inds Inc, Fresenius Kabi Usa, Claris, Mutual Pharm, Prinston Inc, Sun Pharm Inds, Apothecon, Ipca Labs Ltd, Sandoz, Hikma Farmaceutica, Us Pharms Holdings I, Alembic Pharms Ltd, Purepac Pharm, Rubicon Res Pvt Ltd, and Eurohlth Intl Sarl, and is included in thirty-four NDAs. Additional information is available in the individual branded drug profile pages.

There are fifty-six drug master file entries for metoprolol tartrate. Sixty-six suppliers are listed for this compound.

Summary for Generic Name: metoprolol tartrate

Tradenames:2
Patents:0
Applicants:25
NDAs:34
Drug Master File Entries: see list56
Suppliers / Packaging: see list66
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices

Pharmacology for Ingredient: metoprolol tartrate

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Claris
METOPROLOL TARTRATE
metoprolol tartrate
INJECTABLE;INJECTION078950-001Apr 29, 2013RXNo► subscribe► subscribe
Ipca Labs Ltd
METOPROLOL TARTRATE
metoprolol tartrate
TABLET;ORAL078459-002Jun 17, 2008RXNo► subscribe► subscribe
Mylan
METOPROLOL TARTRATE
metoprolol tartrate
TABLET;ORAL076704-003Jan 16, 2004RXYes► subscribe► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: metoprolol tartrate

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Us Pharms Holdings I
LOPRESSOR
metoprolol tartrate
TABLET;ORAL017963-001Approved Prior to Jan 1, 19823,876,802► subscribe
Novartis
LOPRESSOR
metoprolol tartrate
INJECTABLE;INJECTION018704-001Mar 30, 19843,876,802► subscribe
Us Pharms Holdings I
LOPRESSOR
metoprolol tartrate
TABLET;ORAL017963-002Approved Prior to Jan 1, 19823,998,790► subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc